Why is Bafna Pharma. falling/rising?

As of 24-Jul, Bafna Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at 89.00, reflecting a decrease of 0.5 or 0.56%. The stock has underperformed its sector today by 0.91% and has been on a consecutive downward trend for the last two days, resulting in a total drop of 1.58%. Over the past week, the stock has decreased by 1.34%, although it has shown a strong performance over the past month with a gain of 20.25%. Despite this recent decline, the company demonstrates a strong ability to service its debt, with a low Debt to EBITDA ratio of 1.30 times, and has shown healthy long-term growth with net sales increasing at an annual rate of 27.98%. However, profits have fallen by 14.2% over the past year, which may be contributing to the current price movement.
In the broader market context, the Sensex has only slightly declined by 0.09% over the past week, indicating that Bafna Pharmaceuticals' recent performance is not entirely reflective of the overall market trend. While the stock has generated a return of 3.49% over the past year, it has lagged behind the benchmark's performance, which has increased by 2.54% in the same period. The recent increase in institutional investor participation, with a 0.81% rise in their stake, suggests a level of confidence in the company's fundamentals, which may provide some support for the stock in the longer term despite its current downward trajectory.